- level: Info
  location: {}
  message: Importing FHIR PRISM3
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Extracted identifier of type ''Sponsor Protocol Identifier'': ''WA42380'''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: Sponsor org found
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Debug
  location:
    class_name: usdm4_fhir.m11.import_.import_prism3.ImportPRISM3
    method_name: _to_address
  message: 'Address: invalid, {}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Extracted identifier of type ''Amendment Identifier'': ''3'''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: Co sponsor org not found
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Warning
  location: {}
  message: Unable to extract co-sponsor details from associated parties
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: Local sponsor org not found
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Warning
  location: {}
  message: Unable to extract local sponsor details from associated parties
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: Device manufacturer sponsor org not found
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Warning
  location: {}
  message: Unable to extract device manufacturer details from associated parties
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Scope extracted {''global'': True, ''countries'': [], ''regions'': [],
    ''sites'': [], ''unknown'': []}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Impact extracted {''safety_and_rights'': {''safety'': {''substantial'':
    False, ''reason'': ''''}, ''rights'': {''substantial'': False, ''reason'': ''''}},
    ''reliability_and_robustness'': {''reliability'': {''substantial'': False, ''reason'':
    ''''}, ''robustness'': {''substantial'': False, ''reason'': ''''}}}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Amendment extract {''identifier'': ''3'', ''scope'': {''global'': True,
    ''countries'': [], ''regions'': [], ''sites'': [], ''unknown'': []}, ''enrollment'':
    {''value'': 0, ''unit'': ''''}, ''reasons'': {''primary'': ''Primary: Other'',
    ''secondary'': ''Secondary: Other''}, ''summary'': '''', ''impact'': {''safety_and_rights'':
    {''safety'': {''substantial'': False, ''reason'': ''''}, ''rights'': {''substantial'':
    False, ''reason'': ''''}}, ''reliability_and_robustness'': {''reliability'': {''substantial'':
    False, ''reason'': ''''}, ''robustness'': {''substantial'': False, ''reason'':
    ''''}}}, ''changes'': [{''description'': ''Additional secondary efficacy endpoint
    of time to recovery was added'', ''rationale'': ''To facilitate comparison with
    other trials of treatments for COVID-19'', ''section'': ''''}, {''description'':
    ''Text on the sample size and power calculation was updated to incorporate the
    increased enrollment target to maintain 90% power for the primary endpoint, as
    described in the SAP'', ''rationale'': ''The potential for an increase in enrollment
    was included in Version 2 of the protocol, and the confirmation of increased enrollment
    was communicated to sites, Agencies, and ethics committees in the week of 4 May
    2020.'', ''section'': ''''}, {''description'': ''Geographic stratification factors
    were updated'', ''rationale'': ''To address the inclusion of only North American
    and Europe because no sites outside of these regions were included in the study'',
    ''section'': ''''}, {''description'': ''Text on the reporting of pregnancies in
    partner of male patients was removed'', ''rationale'': ''To align with the informed
    consent form and recommendations for tocilizumab in other indications'', ''section'':
    ''Section 5''}, {''description'': ''The method of analysis for the primary endpoint
    was updated'', ''rationale'': ''To utilize a non-parametric method that was determined
    to be a more appropriate method, as described in the SAP'', ''section'': ''''},
    {''description'': ''The method of analysis for the secondary endpoint of clinical
    status at additional timepoints was updated'', ''rationale'': ''To utilize a non-parametric
    method that was determined to be a more appropriate method, as described in the
    SAP'', ''section'': ''Section 6''}, {''description'': ''Selected secondary efficacy
    endpoints were specified as key secondary endpoints'', ''rationale'': ''To address
    Type I error control, as described in the SAP'', ''section'': ''Section 6''},
    {''description'': ''For clarity and as described in the SAP, language on the planned
    interim analyses was updated'', ''rationale'': ''Updated to address the increased
    enrollment target to maintain 90% power for the primary endpoint and the criteria
    for not conducting the interim analyses'', ''section'': ''Section 6''}]}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Extracted identifier of type ''FDA IND Number'': ''IND 148225'''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Extracted identifier of type ''EU CT Number'': ''2020-001154-22'''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Warning
  location: {}
  message: Failed to extract identifier of type 'C218687'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Extracted identifier of type ''NCT Number'': ''NCT04320615'''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Warning
  location: {}
  message: Failed to extract identifier of type 'C218690'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Warning
  location: {}
  message: Failed to extract identifier of type 'C218689'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Debug
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: _create_address
  message: 'Creating address, source data: {''lines'': [''10903 New Hampshire Ave''],
    ''city'': ''Silver Spring'', ''district'': '''', ''state'': ''MD'', ''postalCode'':
    ''20903'', ''country'': ''USA''}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: _create_address
  message: Address set to 10903 New Hampshire Ave, Silver Spring, MD, 20903, United
    States of America
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Debug
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: _create_address
  message: 'Creating address, source data: {''lines'': [''Domenico Scarlattilaan 6''],
    ''city'': ''Amsterdam'', ''district'': '''', ''state'': '''', ''postalCode'':
    ''1083 HS'', ''country'': ''NL''}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: _create_address
  message: Address set to Domenico Scarlattilaan 6, Amsterdam, 1083 HS, Netherlands
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Debug
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: _create_address
  message: 'Creating address, source data: {''lines'': [''National Library of Medicine'',
    ''8600 Rockville Pike''], ''city'': ''Bethesda'', ''district'': '''', ''state'':
    ''MD'', ''postalCode'': ''20894'', ''country'': ''USA''}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: _create_address
  message: Address set to National Library of Medicine, 8600 Rockville Pike, Bethesda,
    MD, 20894, United States of America
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Debug
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: execute
  message: Processing co_sponsor, None
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Debug
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: execute
  message: Processing local_sponsor, None
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Debug
  location:
    class_name: usdm4.assembler.identification_assembler.IdentificationAssembler
    method_name: execute
  message: Processing device_manufacturer, None
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Warning
  location:
    class_name: usdm4.assembler.document_assembler.DocumentAssembler
    method_name: _create_date
  message: No document approval date detected
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.encoder.encoder.Encoder
    method_name: document_status
  message: Document status 'FINAL' decoded as 'C25508', 'Final'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Amendment assembler source data {''identifier'': ''3'', ''scope'': {''global'':
    True, ''countries'': [], ''regions'': [], ''sites'': [], ''unknown'': []}, ''enrollment'':
    {''value'': 0, ''unit'': ''''}, ''reasons'': {''primary'': ''Primary: Other'',
    ''secondary'': ''Secondary: Other''}, ''summary'': '''', ''impact'': {''safety_and_rights'':
    {''safety'': {''substantial'': False, ''reason'': ''''}, ''rights'': {''substantial'':
    False, ''reason'': ''''}}, ''reliability_and_robustness'': {''reliability'': {''substantial'':
    False, ''reason'': ''''}, ''robustness'': {''substantial'': False, ''reason'':
    ''''}}}, ''changes'': [{''description'': ''Additional secondary efficacy endpoint
    of time to recovery was added'', ''rationale'': ''To facilitate comparison with
    other trials of treatments for COVID-19'', ''section'': ''''}, {''description'':
    ''Text on the sample size and power calculation was updated to incorporate the
    increased enrollment target to maintain 90% power for the primary endpoint, as
    described in the SAP'', ''rationale'': ''The potential for an increase in enrollment
    was included in Version 2 of the protocol, and the confirmation of increased enrollment
    was communicated to sites, Agencies, and ethics committees in the week of 4 May
    2020.'', ''section'': ''''}, {''description'': ''Geographic stratification factors
    were updated'', ''rationale'': ''To address the inclusion of only North American
    and Europe because no sites outside of these regions were included in the study'',
    ''section'': ''''}, {''description'': ''Text on the reporting of pregnancies in
    partner of male patients was removed'', ''rationale'': ''To align with the informed
    consent form and recommendations for tocilizumab in other indications'', ''section'':
    ''Section 5''}, {''description'': ''The method of analysis for the primary endpoint
    was updated'', ''rationale'': ''To utilize a non-parametric method that was determined
    to be a more appropriate method, as described in the SAP'', ''section'': ''''},
    {''description'': ''The method of analysis for the secondary endpoint of clinical
    status at additional timepoints was updated'', ''rationale'': ''To utilize a non-parametric
    method that was determined to be a more appropriate method, as described in the
    SAP'', ''section'': ''Section 6''}, {''description'': ''Selected secondary efficacy
    endpoints were specified as key secondary endpoints'', ''rationale'': ''To address
    Type I error control, as described in the SAP'', ''section'': ''Section 6''},
    {''description'': ''For clarity and as described in the SAP, language on the planned
    interim analyses was updated'', ''rationale'': ''Updated to address the increased
    enrollment target to maintain 90% power for the primary endpoint and the criteria
    for not conducting the interim analyses'', ''section'': ''Section 6''}]}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: Amendment reason 'Other' decoded as 'C17649', 'Other'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: Amendment reason 'Other' decoded as 'C17649', 'Other'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _create_scope
  message: Created scope of type Global
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location: {}
  message: 'Scopes created in assembler, geo: [GeographicScope(id=''GeographicScope_1'',
    extensionAttributes=[], type=Code(id=''Code_42'', extensionAttributes=[], code=''C68846'',
    codeSystem=''http://www.cdisc.org'', codeSystemVersion=''2025-09-26'', decode=''Global'',
    instanceType=''Code''), code=None, instanceType=''GeographicScope'')], sites:
    None'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _create_amendment_impact
  message: 'Creating amendment impacts using {''safety_and_rights'': {''safety'':
    {''substantial'': False, ''reason'': ''''}, ''rights'': {''substantial'': False,
    ''reason'': ''''}}, ''reliability_and_robustness'': {''reliability'': {''substantial'':
    False, ''reason'': ''''}, ''robustness'': {''substantial'': False, ''reason'':
    ''''}}}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Error
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _extract_section_numer_and_title
  message: Failed to extract section ref from ''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Error
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _extract_section_numer_and_title
  message: Failed to extract section ref from ''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Error
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _extract_section_numer_and_title
  message: Failed to extract section ref from ''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _extract_section_numer_and_title
  message: 'Extracted section ref from ''Section 5'' -> {''sectionNumber'': ''5'',
    ''sectionTitle'': '''', ''appliesToId'': ''StudyDefinitionDocument_1'', ''id'':
    ''DocumentContentReference_1'', ''instanceType'': ''DocumentContentReference''}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Error
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _extract_section_numer_and_title
  message: Failed to extract section ref from ''
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _extract_section_numer_and_title
  message: 'Extracted section ref from ''Section 6'' -> {''sectionNumber'': ''6'',
    ''sectionTitle'': '''', ''appliesToId'': ''StudyDefinitionDocument_1'', ''id'':
    ''DocumentContentReference_2'', ''instanceType'': ''DocumentContentReference''}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _extract_section_numer_and_title
  message: 'Extracted section ref from ''Section 6'' -> {''sectionNumber'': ''6'',
    ''sectionTitle'': '''', ''appliesToId'': ''StudyDefinitionDocument_1'', ''id'':
    ''DocumentContentReference_3'', ''instanceType'': ''DocumentContentReference''}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.amendments_assembler.AmenementsAssembler
    method_name: _extract_section_numer_and_title
  message: 'Extracted section ref from ''Section 6'' -> {''sectionNumber'': ''6'',
    ''sectionTitle'': '''', ''appliesToId'': ''StudyDefinitionDocument_1'', ''id'':
    ''DocumentContentReference_4'', ''instanceType'': ''DocumentContentReference''}'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.encoder.encoder.Encoder
    method_name: phase
  message: Trial phase '3' decoded as 'C15602', 'Phase 3', using M11 decode
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Warning
  location:
    class_name: usdm4.assembler.study_assembler.StudyAssembler
    method_name: _create_date
  message: No sponsor approval date detected
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
- level: Info
  location:
    class_name: usdm4.assembler.study_assembler.StudyAssembler
    method_name: _get_study_name_label
  message: Study name set to 'WA42380'
  timestamp: YYYY-MM-DD HH:MM:SS.nnnnnn
  type: ''
